MedTech Acquisition Corporation Registered Shs Aktie
WKN DE: A3EP5W / ISIN: US89680M1018
|
27.03.2025 13:00:02
|
TriSalus Life Sciences, Inc. Q4 Loss Decreases, But Misses Estimates
(RTTNews) - TriSalus Life Sciences, Inc. (TLSI) released Loss for fourth quarter that decreased from the same period last year but missed the Street estimates.
The company's bottom line came in at -$10.89 million, or -$0.40 per share. This compares with -$36.44 million, or -$1.57 per share, last year.
Analysts on average had expected the company to earn -$0.35 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 44.4% to $8.26 million from $5.72 million last year.
TriSalus Life Sciences, Inc. earnings at a glance (GAAP) :
-Earnings: -$10.89 Mln. vs. -$36.44 Mln. last year. -EPS: -$0.40 vs. -$1.57 last year. -Revenue: $8.26 Mln vs. $5.72 Mln last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu MedTech Acquisition Corporation Registered Shsmehr Nachrichten
|
12.11.25 |
Ausblick: MedTech Acquisition stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) | |
|
11.08.25 |
Ausblick: MedTech Acquisition legt Quartalsergebnis vor (finanzen.net) |